Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-04 to 2024-06-05
Current total value of award: $6.27
Description: 4564815259!INSULIN HUMAN INJECTION MODIFIED 100 USP